IL6 and Bjornstad syndrome: Almost the same results were obtained by Locci et al. [102] in a longitudinal study where intravaginal bLf treatment, consisting of 300 mg bLf for 21 days in asymptomatic women at low risk for PTD, was effective in lowering cervico-vaginal IL-6 levels and improving cervical length [102].